News Prostate help is ‘too dear’

This week’s

The People - - LIFESTYLE -

PA­TIENTS with ad­vanced prostate can­cer are be­ing de­nied a key drug.

NHS watch­dog Nice, the Na­tional In­sti­tute for Health and Care Ex­cel­lence, ruled abi­raterone, which has fewer side ef­fects than oth­ers, can­not be of­fered be­fore stan­dard ther­apy such as chemo. Nice said the price of about £3,000 a month is not cost-ef­fec­tive.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.